ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIE THERESA PIMENTEL M.D

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,883Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 910

$797K Total Retail Price of All Prescriptions

Rank: 43 out of 910

602 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,017 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 390 364 1 1
AMLODIPINE BESYLATE 359 342 2 4
LISINOPRIL 348 334 3 2
SIMVASTATIN 331 299 4 3
ATORVASTATIN CALCIUM 294 275 5 14
LOSARTAN POTASSIUM 224 198 6 15
OMEPRAZOLE 221 190 7 5
METFORMIN HCL 221 192 7 6
LOVASTATIN 218 215 9 20
CARVEDILOL 199 196 10 36
HYDROCODONE-ACETAMINOPHEN 186 162 S3 11 8
ALENDRONATE SODIUM 186 174 11 22
FUROSEMIDE 169 150 13 9
FENOFIBRATE 166 151 14 55
GABAPENTIN 154 137 15 13
VYTORIN 144 142 16 82
METOPROLOL TARTRATE 137 133 17 7
JANUVIA 123 115 18 69
DONEPEZIL HCL 110 110 19 32
POTASSIUM CHLORIDE 101 98 20 18
ZETIA 98 92 21 84
TAMSULOSIN HCL 95 89 22 29
PANTOPRAZOLE SODIUM 95 78 22 27
GLIMEPIRIDE 94 94 24 56
FLUOXETINE HCL 89 78 25 49
BENAZEPRIL HCL 88 86 26 89
ATENOLOL 84 81 27 10
ADVAIR DISKUS 78 75 28 45
ZOLPIDEM TARTRATE 77 69 29 17
CITALOPRAM HBR 77 74 29 19
ALLOPURINOL 74 73 31 33
SERTRALINE HCL 73 68 32 24
EVISTA 71 71 33 139
PRAVASTATIN SODIUM 70 58 34 16
PEN NEEDLE 70 63 34 124
LANTUS SOLOSTAR 70 56 34 112
OXYCODONE-ACETAMINOPHEN 70 49 S2 34 31
CLOPIDOGREL 69 69 38 35
TRILIPIX 68 52 39 185
SPIRIVA 66 56 40 74
SYNTHROID 66 64 40 54
METOPROLOL SUCCINATE 65 47 42 21
NAMENDA 64 64 43 57
PRANDIN 63 56 44 347
FINASTERIDE 61 60 45 59
CYCLOBENZAPRINE HCL 59 55 R 46 80
HYDROCHLOROTHIAZIDE 59 54 46 12
LEVOXYL 58 58 48 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 55 49 44
TRAMADOL HCL 57 54 49 25
PRAMIPEXOLE DIHYDROCHLORIDE 56 49 51 191
WARFARIN SODIUM 55 54 52 11
AMLODIPINE BESYLATE-BENAZEPRIL 55 51 52 166
PLAVIX 55 55 52 53
AMITRIPTYLINE HCL 54 49 R 55 72
CRESTOR 54 51 55 26
TRAZODONE HCL 50 38 57 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.